Related Experiment Video
Updated: Aug 26, 2025
07:55
The Influence of Liver Resection on Intrahepatic Tumor Growth
Published on: April 9, 2016
9.5K
Making liver cancer cells go ARGh!
Alessa L Henneberg1,2, Christiane A Opitz1,3
1Metabolic Crosstalk in Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
The EMBO Journal
|October 12, 2022
Summary
Hepatocellular carcinoma cells survive by downregulating urea cycle enzymes and taking up arginine. Targeting these pathways offers new strategies for liver cancer treatment.
Area of Science:
- Oncology
- Biochemistry
- Cell Biology
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern.
- Understanding cancer cell metabolism is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the metabolic adaptations of hepatocellular carcinoma cells.
- To identify novel therapeutic targets for liver cancer.
Main Methods:
- Analysis of urea cycle enzyme expression in HCC cells.
- Assessment of arginine uptake and utilization.
- Investigation of GCN2 kinase signaling pathways.
Main Results:
- HCC cells downregulate key urea cycle enzymes.
- These cancer cells depend on exogenous arginine for survival.
- GCN2 kinase-dependent cell-cycle arrest is essential for HCC cell viability.
Conclusions:
- Hepatocellular carcinoma cells exhibit altered metabolic dependencies.
- Targeting urea cycle enzymes and arginine uptake presents a potential combinatorial therapeutic strategy.
- Inhibition of GCN2 kinase may be beneficial in treating liver cancer.
